{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T17:54:56Z","timestamp":1759341296906,"version":"3.41.2"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005969","name":"University of Bologna","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005969","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reports"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.pharep.2018.10.007","type":"journal-article","created":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T14:02:18Z","timestamp":1539266538000},"page":"128-132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Neutral\/negative \u03b11-AR antagonists and calcium channel blockers at comparison in functional tests on guinea-pig smooth muscle and myocardium"],"prefix":"10.1007","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3525-1531","authenticated-orcid":false,"given":"Matteo","family":"Micucci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8388-7441","authenticated-orcid":false,"given":"Alberto","family":"Chiarini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8454-9740","authenticated-orcid":false,"given":"Roberta","family":"Budriesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"10.1016\/j.pharep.2018.10.007_bib0005","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1021\/jm00217a002","article-title":"Absolute configuration of glycerol derivatives. 4. Synthesis and pharmacological activity of chiral 2-alkylaminomethylbenzodioxans, competitive alpha-adrenergic antagonists","volume":"20","author":"Nelson","year":"1977","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharep.2018.10.007_bib0010","doi-asserted-by":"crossref","first-page":"6192","DOI":"10.1016\/j.bmcl.2007.09.015","article-title":"Peptidomimetic inhibitors of farnesyltransferase with high in vitro activity and significant cellular potency","volume":"17","author":"Bolchi","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.pharep.2018.10.007_bib0015","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.bmcl.2008.12.002","article-title":"5-(2-pyrrolidinyl)oxazolidinones and 2-(2-pyrrolidinyl)benzodioxanes: synthesis of all the stereoisomers and alpha4beta2 nicotinic affinity","volume":"19","author":"Pallavicini","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.pharep.2018.10.007_bib0020","doi-asserted-by":"crossref","first-page":"7588","DOI":"10.1021\/jm200937t","article-title":"Unichiral 2-(2\u2019-pyrrolidinyl)-1,4-benzodioxane: the 2R, 2\u2019S diastereomer of the N-methyl-7-hydroxy analogue is a potent alpha4beta2- and alpha6beta2-nicotinic acetylcholine receptor partial agonist","volume":"54","author":"Bolchi","year":"2011","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharep.2018.10.007_bib0025","doi-asserted-by":"crossref","first-page":"6665","DOI":"10.1021\/acs.jmedchem.5b00904","article-title":"Chemistry and pharmacology of a series of unichiral analogues of 2-(2-pyrrolidinyl)-1,4-benzodioxane, prolinol phenyl ether, and prolinol 3-pyridyl ether designed as alpha4beta2-nicotinic acetylcholine receptor agonists","volume":"58","author":"Bolchi","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharep.2018.10.007_bib0030","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ejmech.2014.09.100","article-title":"Benzodioxane-benzamides as new bacterial cell division inhibitors","volume":"89","author":"Chiodini","year":"2015","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.pharep.2018.10.007_bib0035","doi-asserted-by":"crossref","first-page":"7140","DOI":"10.1021\/jm060358r","article-title":"WB4101-related compounds: new, subtype-selective alpha1-adrenoreceptor antagonists (or inverse agonists?)","volume":"49","author":"Pallavicini","year":"2006","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharep.2018.10.007_bib0040","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ejmech.2012.09.049","article-title":"Affinity and activity profiling of unichiral 8-substituted 1,4-benzodioxane analogues of WB4101 reveals a potent and selective alpha1B-adrenoceptor antagonist","volume":"58","author":"Fumagalli","year":"2012","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.pharep.2018.10.007_bib0045","doi-asserted-by":"crossref","first-page":"6402","DOI":"10.1021\/jm400867d","article-title":"6-methoxy-7-benzofuranoxy and 6-methoxy-7-indolyloxy analogues of 2-[2-(2,6-dimethoxyphenoxy)ethyl]aminomethyl-1,4-benzodioxane (WB4101): discovery of a potent and selective alpha1D-adrenoceptor antagonist","volume":"56","author":"Fumagalli","year":"2013","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharep.2018.10.007_bib0050","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1476-5381.1996.tb15689.x","article-title":"Functional evidence of inverse agonism in vascular smooth muscle","volume":"119","author":"Noguera","year":"1996","journal-title":"Br J Pharmacol"},{"issue":"67","key":"10.1016\/j.pharep.2018.10.007_bib0055","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00018-009-0174-4","article-title":"Subtypes of functional alpha1-adrenoceptor","volume":"2010","author":"Docherty","year":"2010","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.pharep.2018.10.007_bib0060","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1124\/pr.112.007203","article-title":"Cardiac alpha1-adrenergic receptors: novel aspects of expression, signaling mechanisms, physiologic function, and clinical importance","volume":"66","author":"O\u2019Connell","year":"2014","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.pharep.2018.10.007_bib0065","doi-asserted-by":"crossref","first-page":"4937","DOI":"10.1016\/j.bmc.2004.06.040","article-title":"Structure-affinity studies for a novel series of homochiral naphtho and tetrahydronaphtho analogues of alpha1 antagonist WB-4101","volume":"12","author":"Bolchi","year":"2004","journal-title":"Bioorg Med Chem"},{"year":"1987","series-title":"Manual of pharmacologic calculations with computer programs","author":"Tallarida","key":"10.1016\/j.pharep.2018.10.007_bib0070"},{"key":"10.1016\/j.pharep.2018.10.007_bib0075","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1540\/jsmr.35.181","article-title":"Alpha1-adrenoceptor in the guinea pig thoracic aorta","volume":"35","author":"Yamamoto","year":"1999","journal-title":"J Smooth Muscle Res"},{"key":"10.1016\/j.pharep.2018.10.007_bib0080","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1750-2187-3-6","article-title":"The alpha1D-adrenergic receptor is expressed intracellularly and coupled to increases in intracellular calcium and reactive oxygen species in human aortic smooth muscle cells","volume":"3","author":"Garcia-Cazarin","year":"2008","journal-title":"J Mol Signal"},{"key":"10.1016\/j.pharep.2018.10.007_bib0085","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1073\/pnas.78.2.1237","article-title":"Alpha-adrenergic antagonists as possible calcium channel inhibitors","volume":"78","author":"Atlas","year":"1981","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharep.2018.10.007_bib0090","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1161\/CIRCRESAHA.107.167734","article-title":"Interaction of alpha1-adrenoceptor subtypes with different G proteins induces opposite effects on cardiac L-type Ca2+ channel","volume":"102","author":"O-Uchi","year":"2008","journal-title":"Circ Res"},{"key":"10.1016\/j.pharep.2018.10.007_bib0095","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/0306-3623(88)90161-9","article-title":"Ca-entry blockers, verapamil and diltiazem, on alpha1-adrenoceptors in thoracic aorta, renal artery and portal vein from rabbit","volume":"19","author":"Koike","year":"1988","journal-title":"Gen Pharm"},{"key":"10.1016\/j.pharep.2018.10.007_bib0100","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1474-8673.1983.tb00532.x","article-title":"Effects of diltiazem on phasic and tonic activity in rat portal vein","volume":"3","author":"Hicks","year":"1983","journal-title":"J Auton Pharmac"},{"key":"10.1016\/j.pharep.2018.10.007_bib0105","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ejphar.2015.04.011","article-title":"Basal activity of voltage-gated Ca2+ channels controls the IP3-mediated contraction by alpha1-adrenoceptor stimulation of mouse aorta segments","volume":"760","author":"Leloup","year":"2015","journal-title":"Eur J Pharmacol"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114018303670?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114018303670?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:37:47Z","timestamp":1752611867000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.pharep.2018.10.007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S1734114018303670"],"URL":"https:\/\/doi.org\/10.1016\/j.pharep.2018.10.007","relation":{},"ISSN":["1734-1140"],"issn-type":[{"type":"print","value":"1734-1140"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neutral\/negative \u03b11-AR antagonists and calcium channel blockers at comparison in functional tests on guinea-pig smooth muscle and myocardium","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharep.2018.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}